Home / Pharmaceutical company intelligence
Epharm Laboratories logo
Pharmaceutical company intelligence

Epharm Laboratories products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer · Karachi · Pakistan

Karachi pharmaceutical manufacturer with more than two decades of operations, a broad registered portfolio and domestic and international market ambitions.

Epharm Laboratories products in Pakistan

Epharm Laboratories has 144 medicine presentations registered in Pakistan under 75 brands, covering 67 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Keley (Cephalexin), Teltan (Telmisartan + Hydrochlorothiazide), Astron (Moxifloxacin) and Epan (Cefixime). 144 products have an official DRAP price on MedInfoBase. See all 75 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation13 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date30 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
A-40, Road No. 1, S.I.T.E. Super Highway Industrial Area, North Karachi, Karachi 75340, Pakistan · 75340
Phone
+92 300 0268033
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000598 E-Pharm Laboratories. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000598 144 linked products · source seen 13 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx153public portfolio records represented
REG135unique registrations represented
IDX6indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER69registry-verified exact registrations
PKR144current validated price records
G67generic molecules in indexed catalogue
DF12dosage-form groups
TA14therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage94%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage91%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixEpharm LaboratoriesShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/epharm-laboratoriesGenerated 13 Nov 2026Anti-infectives82 · 57%Cardiovascular17 · 12%Gastrointestinal & hepatology13 · 9%Vitamins, minerals & nutrition9 · 6%Hematology & thrombosis4 · 3%Respiratory & allergy4 · 3%CNS & mental health3 · 2%Other therapeutic areas12 · 8%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioEpharm LaboratoriesDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/epharm-laboratoriesGenerated 13 Nov 2026144presentationsTablet59 · 41%Injection29 · 20%Capsule19 · 13%Syrup8 · 6%Drops7 · 5%Suspension7 · 5%Other forms15 · 10%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionEpharm LaboratoriesCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/epharm-laboratoriesGenerated 13 Nov 2026131comparable productsBelow peer median76 · 58%Near peer median34 · 26%Above peer median21 · 16%Company median price position-6.9%Lowest-price equivalents19Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsEpharm LaboratoriesCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/epharm-laboratoriesGenerated 13 Nov 2026Nabiqasim Industries (Pvt) Ltd.,42 shared63% overlapMediate Pharmaceutical Pvt Ltd38 shared57% overlapNeutro Pharma (Pvt.) Ltd.,38 shared57% overlapCCL Pharmaceuticals (Pvt.) Limited37 shared55% overlapZafa Pharmaceutical Laboratories (P…37 shared55% overlapShaigan Pharmaceuticals (Pvt) Ltd37 shared55% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet59 products
Injection29 products
Capsule19 products
Syrup8 products
Drops7 products
Suspension7 products
Cream4 products
Infusion4 products
Gel2 products
Ointment2 products
Solution2 products
Pessary1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Epharm Laboratories is priced against the market

131 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers126Distinct registrations among indexed, published, presentation-validated products only
Verified price observations144
Products with a verified price144
Products with multiple price observations0
Source records with multiple versions144
Latest portfolio source check22 Sep 2026
Latest effective price date30 Jul 2026
Latest source observation13 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

135 unique registration(s) · 6 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Keley Cephalexin 125 mg/5 mL Dry suspension 60ml 058414 PKR 114.55 PKR 1.91/mL 🔒 Pharma Pro
Keley Cephalexin 250 mg/5 mL Dry suspension 60ml 058415 PKR 198.03 PKR 3.30/mL 🔒 Pharma Pro
Keley Cephalexin 250 mg Capsule 12's 058416 PKR 198.03 PKR 16.50/capsule 🔒 Pharma Pro
Keley Cephalexin 250 mg Capsule 16's 058416 PKR 176.68 PKR 11.04/capsule 🔒 Pharma Pro
Keley Cephalexin 500 mg Capsule 12's 058417 PKR 396.42 PKR 33.04/capsule 🔒 Pharma Pro
Keley Cephalexin 500 mg Capsule 16's 058417 PKR 231.91 PKR 14.49/capsule 🔒 Pharma Pro
A to Z

All 75 Epharm Laboratories brands in Pakistan

  • Algixim Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Anibret Terbinafine · 1 % cream, 125 mg tablet, 250 mg tablet
  • Astron Moxifloxacin · 400 mg tablet, 400 mg/250 mL infusion, 5 mg/mL drops
  • Atenopharm Atenolol · 100 mg tablet, 25 mg tablet, 50 mg tablet
  • Atorpharm Atorvastatin · 10 mg tablet, 20 mg tablet
  • Autoben Albendazole · 200 mg tablet
  • Avlochlor-HS Hydroxychloroquine · 200 mg tablet
  • Avlochlor-P Chloroquine · 250 mg tablet, 50 mg/5 mL syrup
  • Betnopharm Betamethasone valerate · 1 mg/g (0.1%) ointment
  • Betol Timolol · 0.5 % solution
  • Bisadyl Bisacodyl · 5 mg tablet
  • Buscopharm Hyoscine butylbromide · 20 mg/mL injection
  • Cadlizo Linezolid · 400 mg tablet, 600 mg tablet
  • Ceftin Cefuroxime · 125 mg/5 mL suspension, 250 mg injection, 750 mg injection
  • Citazest Metformin · 500 mg tablet, 850 mg tablet
  • Conate Clotrimazole · 1 % cream
  • Conate s Clotrimazole · 0.5 g pessary
  • Cozole Fluconazole · 150 mg capsule
  • D.Dron Dexamethasone · 4 mg/mL injection
  • Dxcyne Doxycycline · 100 mg capsule
  • Ekasin Amikacin · 100 mg/2 mL injection, 500 mg/2 mL injection
  • Emycin Azithromycin · 250 mg capsule
  • Epan Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
  • Epan-DS Cefixime · 200 mg/5 mL suspension
  • Ephacard Amlodipine · 5 mg tablet
  • Ephagent Gentamicin · 40 mg/mL injection
  • Ephagent Eye and Ear Gentamicin · 0.3 g/100 mL drops
  • Ephamic Tranexamic acid · 250 mg/5 mL injection, 500 mg capsule
  • Ephamide Furosemide · 20 mg/2 mL injection
  • Ephasaline Nasal Sodium chloride · 0.65 % drops
  • Ephtum Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
  • Eptrim Artemether · 20 mg/mL injection, 40 mg/mL injection, 80 mg/mL injection
  • Eptrim-DS 40 Artemether + Lumefantrine · 40 mg + 240 mg tablet
  • Eptrim-M 20 Artemether + Lumefantrine · 20 mg + 120 mg tablet
  • Eptrim-X 80 Artemether + Lumefantrine · 80 mg + 480 mg tablet
  • Ethanzap-10 Olanzapine · 10 mg tablet
  • Ethanzap-5 Olanzapine · 5 mg tablet
  • Faremicin Fosfomycin · 500 mg capsule
  • Feofar Letrozole · 2.5 mg tablet
  • Fledore Fluoxetine · 20 mg capsule
  • Flociprin Ciprofloxacin · 200 mg/100 mL infusion, 250 mg tablet, 500 mg tablet
  • Follinemic Elemental Iron · 40 mg/15 mL syrup
  • Frutcee Chewable Ascorbic acid · 500 mg tablet
  • Iropharm Elemental Iron · 100 mg tablet, 50 mg/5 mL syrup
  • Iropharm-F Iron + Folic acid · 100 mg + 0.35 mg tablet, 50 mg/5 mL + 0.35 mg/5 mL syrup
  • IT Itraconazole · 100 mg capsule
  • Izmepra Omeprazole · 20 mg capsule, 40 mg capsule
  • Keley Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
  • Klath Clarithromycin · 250 mg tablet, 500 mg tablet
  • L-Tan Losartan · 50 mg tablet
  • Lacnan Lactulose · 3.35 g/5 mL syrup
  • Levopharm Levofloxacin · 250 mg tablet, 500 mg tablet, 500 mg/100 mL infusion
  • Lignopharm Lidocaine · 1 % injection, 2% gel
  • Lopidrel Clopidogrel · 75 mg tablet
  • Loratlax Loratadine · 10 mg tablet, 5 mg/5 mL syrup
  • Mazitrom Azithromycin · 250 mg tablet, 500 mg tablet
  • Methpharm Permethrin · 50 mg/g cream
  • Midrozole Miconazole · 2 % gel
  • Nystapharm Nystatin · 100,000 units/mL drops
  • O-Mide Loperamide HCl · 2 mg capsule
  • Oxy Tetracycline · 250 mg capsule
  • PC-Trax Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Reneph Ranitidine · 150 mg tablet, 50 mg/2 mL injection
  • Ribapharm Ribavirin · 500 mg tablet, 600 mg tablet
  • Seltaferon Oseltamivir · 12 mg/mL suspension, 75 mg capsule
  • Silvopharm Silver sulfadiazine · 1 % cream
  • Synthivan Lopinavir + Ritonavir · 200 mg + 50 mg tablet
  • Taripharm Ofloxacin · 0.3 % drops, 200 mg tablet, 200 mg/100 mL infusion
  • Teltan Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
  • Tropix Tropicamide · 1 % drops
  • Valenfer Iron · 100 mg/5 mL injection
  • Ventopharm Salbutamol · 2 mg tablet, 4 mg tablet
  • Vomilide Metoclopramide · 10 mg tablet, 10 mg/2 mL injection, 5 mg/5 mL solution
  • Zonapril Lisinopril · 10 mg tablet, 20 mg tablet, 5 mg tablet
  • Zuplenz Ondansetron · 8 mg/4 mL injection
Questions

Epharm Laboratories: common questions

How many products does Epharm Laboratories have in Pakistan?

Epharm Laboratories has 144 registered medicine presentations in Pakistan, sold under 75 brands and covering 67 generic medicines.

What are the main brands of Epharm Laboratories?

By number of registered strengths and packs, its largest brands are Keley (Cephalexin), Teltan (Telmisartan + Hydrochlorothiazide), Astron (Moxifloxacin), Epan (Cefixime) and Flociprin (Ciprofloxacin). This is not a sales ranking.

Which therapy areas does Epharm Laboratories cover?

The most products are in Anti-infectives (82), Cardiovascular (17), Gastrointestinal & hepatology (13), Vitamins, minerals & nutrition (9) and Hematology & thrombosis (4).

Where can I see Epharm Laboratories medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Epharm Laboratories — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/company/epharm-laboratories/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9